Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against <italic toggle="yes">Streptococcus pyogenes</italic>

ABSTRACT The clinical development of group A streptococcal (GAS) vaccines will require the implementation of a standardized, high-throughput assay to measure the activity of functional opsonic antibodies in vaccine recipients. In the present study, we adapted and modified the HL-60-based protocol th...

Full description

Bibliographic Details
Main Authors: Sanaz Salehi, Claudia M. Hohn, Thomas A. Penfound, James B. Dale
Format: Article
Language:English
Published: American Society for Microbiology 2018-12-01
Series:mSphere
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mSphere.00617-18
_version_ 1818834829637058560
author Sanaz Salehi
Claudia M. Hohn
Thomas A. Penfound
James B. Dale
author_facet Sanaz Salehi
Claudia M. Hohn
Thomas A. Penfound
James B. Dale
author_sort Sanaz Salehi
collection DOAJ
description ABSTRACT The clinical development of group A streptococcal (GAS) vaccines will require the implementation of a standardized, high-throughput assay to measure the activity of functional opsonic antibodies in vaccine recipients. In the present study, we adapted and modified the HL-60-based protocol that was developed for the detection of opsonic antibodies against Streptococcus pneumoniae for use with multiple M types of GAS. Modifications of the assay conditions permitted the evaluation of 21 different M types of GAS in the assay. The specificity of the antibody-mediated opsonization was demonstrated by inhibition with homologous, but not heterologous, M proteins. Maximum rates of opsonophagocytic killing (OPK) of 14 different M types promoted by rabbit antiserum against the 30-valent M protein-based vaccine were comparable in whole-blood and HL-60 assays. Data are also presented showing OPK serum titers (opsonic index) of naturally acquired human antibodies present in IVIG [intravenous immune globulin (human)]. Results of the HL-60 assay performed on different days using 21 different M types of GAS and IVIG as the antibody source were significantly concordant. This report indicates that the OPK assay conditions may be optimized for the measurement of opsonic antibodies against a number of epidemiologically important M types of GAS and, once standardized, should facilitate the clinical development of effective vaccines to prevent these infections. IMPORTANCE Measuring functional opsonic antibodies against group A streptococci is an important component of the clinical development path for effective vaccines. Prior studies have used an assay developed over 60 years ago that relied on whole human blood as the source of phagocytes and complement, both of which are critical components of antibody-mediated killing assays. In this study, we adapted an assay that uses the HL-60 human promyelocytic leukemia cell line as phagocytic cells and baby rabbit serum as a source of complement for detection of opsonic antibodies against group A streptococci. On the basis of some of the known biological characteristics of the bacteria, we modified the assay conditions to support the evaluation of 21 epidemiologically important M types and demonstrated the utility and reproducibility of the assay for measurement of functional opsonic antibody levels.
first_indexed 2024-12-19T02:41:02Z
format Article
id doaj.art-30a94378ff9a4a768bff82461ec567d5
institution Directory Open Access Journal
issn 2379-5042
language English
last_indexed 2024-12-19T02:41:02Z
publishDate 2018-12-01
publisher American Society for Microbiology
record_format Article
series mSphere
spelling doaj.art-30a94378ff9a4a768bff82461ec567d52022-12-21T20:39:08ZengAmerican Society for MicrobiologymSphere2379-50422018-12-013610.1128/mSphere.00617-18Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against <italic toggle="yes">Streptococcus pyogenes</italic>Sanaz Salehi0Claudia M. Hohn1Thomas A. Penfound2James B. Dale3Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USADepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USADepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USADepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USAABSTRACT The clinical development of group A streptococcal (GAS) vaccines will require the implementation of a standardized, high-throughput assay to measure the activity of functional opsonic antibodies in vaccine recipients. In the present study, we adapted and modified the HL-60-based protocol that was developed for the detection of opsonic antibodies against Streptococcus pneumoniae for use with multiple M types of GAS. Modifications of the assay conditions permitted the evaluation of 21 different M types of GAS in the assay. The specificity of the antibody-mediated opsonization was demonstrated by inhibition with homologous, but not heterologous, M proteins. Maximum rates of opsonophagocytic killing (OPK) of 14 different M types promoted by rabbit antiserum against the 30-valent M protein-based vaccine were comparable in whole-blood and HL-60 assays. Data are also presented showing OPK serum titers (opsonic index) of naturally acquired human antibodies present in IVIG [intravenous immune globulin (human)]. Results of the HL-60 assay performed on different days using 21 different M types of GAS and IVIG as the antibody source were significantly concordant. This report indicates that the OPK assay conditions may be optimized for the measurement of opsonic antibodies against a number of epidemiologically important M types of GAS and, once standardized, should facilitate the clinical development of effective vaccines to prevent these infections. IMPORTANCE Measuring functional opsonic antibodies against group A streptococci is an important component of the clinical development path for effective vaccines. Prior studies have used an assay developed over 60 years ago that relied on whole human blood as the source of phagocytes and complement, both of which are critical components of antibody-mediated killing assays. In this study, we adapted an assay that uses the HL-60 human promyelocytic leukemia cell line as phagocytic cells and baby rabbit serum as a source of complement for detection of opsonic antibodies against group A streptococci. On the basis of some of the known biological characteristics of the bacteria, we modified the assay conditions to support the evaluation of 21 epidemiologically important M types and demonstrated the utility and reproducibility of the assay for measurement of functional opsonic antibody levels.https://journals.asm.org/doi/10.1128/mSphere.00617-18Streptococcus pyogenesgroup A streptococcusopsonic antibodiesvaccines
spellingShingle Sanaz Salehi
Claudia M. Hohn
Thomas A. Penfound
James B. Dale
Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against <italic toggle="yes">Streptococcus pyogenes</italic>
mSphere
Streptococcus pyogenes
group A streptococcus
opsonic antibodies
vaccines
title Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against <italic toggle="yes">Streptococcus pyogenes</italic>
title_full Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against <italic toggle="yes">Streptococcus pyogenes</italic>
title_fullStr Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against <italic toggle="yes">Streptococcus pyogenes</italic>
title_full_unstemmed Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against <italic toggle="yes">Streptococcus pyogenes</italic>
title_short Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against <italic toggle="yes">Streptococcus pyogenes</italic>
title_sort development of an opsonophagocytic killing assay using hl 60 cells for detection of functional antibodies against italic toggle yes streptococcus pyogenes italic
topic Streptococcus pyogenes
group A streptococcus
opsonic antibodies
vaccines
url https://journals.asm.org/doi/10.1128/mSphere.00617-18
work_keys_str_mv AT sanazsalehi developmentofanopsonophagocytickillingassayusinghl60cellsfordetectionoffunctionalantibodiesagainstitalictoggleyesstreptococcuspyogenesitalic
AT claudiamhohn developmentofanopsonophagocytickillingassayusinghl60cellsfordetectionoffunctionalantibodiesagainstitalictoggleyesstreptococcuspyogenesitalic
AT thomasapenfound developmentofanopsonophagocytickillingassayusinghl60cellsfordetectionoffunctionalantibodiesagainstitalictoggleyesstreptococcuspyogenesitalic
AT jamesbdale developmentofanopsonophagocytickillingassayusinghl60cellsfordetectionoffunctionalantibodiesagainstitalictoggleyesstreptococcuspyogenesitalic